Erratum to: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis (Nature Medicine, (2017), 23, 5, (590-600), 10.1038/nm.4305)

  • Luigina Romani
  • , Vasilis Oikonomou
  • , Silvia Moretti
  • , Rossana G. Iannitti
  • , Maria Cristina D’Adamo
  • , Valeria R. Villella
  • , Marilena Pariano
  • , Luigi Sforna
  • , Monica Borghi
  • , Marina M. Bellet
  • , Francesca Fallarino
  • , Maria Teresa Pallotta
  • , Giuseppe Servillo
  • , Eleonora Ferrari
  • , Paolo Puccetti
  • , Guido Kroemer
  • , Mauro Pessia
  • , Luigi Maiuri
  • , Allan L. Goldstein
  • , Enrico Garaci

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the version of this article originally published, the amino acid sequence for Tα1 described in the Online Methods is incorrect. The sequence is described as “Ac-SDAAVDTSSEITTJDLKEKKEVVEEAEN-OH”. It should be “Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN-OH”. The error has been corrected in the HTML and PDF versions of this article.

Original languageEnglish
Pages (from-to)1482
Number of pages1
JournalNature Medicine
Volume24
Issue number9
DOIs
Publication statusPublished - Sept 1 2018
Externally publishedYes

ASJC Scopus subject areas

  • General Biochemistry,Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Erratum to: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis (Nature Medicine, (2017), 23, 5, (590-600), 10.1038/nm.4305)'. Together they form a unique fingerprint.

Cite this